Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,075
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
for
Advanced HR+/HER2- Breast Cancer,
Location: Houston TX, Nashville TN, St Louis MO, Fort Myers FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06726148
Phase1, Phase2, Recruiting
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)
for
Oligometastatic Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06004336
Phase2, Recruiting
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
for
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Location: Houston TX, Tampa FL
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06616636
Phase1, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Houston TX, San Antonio TX, Dallas TX, Oklahoma City OK,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)
for
Schizophrenia
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18 - 60
Code: NCT06961916
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: The Woodlands TX, Austin TX, Fredericksburg TX,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Houston TX, Austin TX, Corpus Christi TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase3, Recruiting
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for
Endometrial Adenocarcinoma
Location: Houston TX, Shreveport LA, New Orleans LA,
Sponsor: Acrivon Therapeutics
Sex: Female
Age: 18+
Code: NCT05548296
Phase2, Recruiting
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
for
Brain Metastases
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06649058
Phase2, Recruiting
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Sugarland TX, Nashville TN, Atlanta GA, Omaha NE,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 18+
Code: NCT06822426
Phase3, Recruiting
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
for
Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05536349
Phase2, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Location: Houston TX, Birmingham AL, Nashville TN, Atlanta GA,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 12+
Code: NCT02693535
Phase2, Recruiting
MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
for
Glioma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04373720
Recruiting
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
for
Peripheral Nerve Injuries
Location: Houston TX, San Antonio TX, Columbus OH, Baltimore MD,
Sponsor: Auxilium Biotechnologies
Sex: All
Age: 18 - 70+
Code: NCT06529835
Recruiting
A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma
for
Solid Tumor, Adult Lymphoma
Location: Houston TX, Pittsburgh PA, Duarte CA
Sponsor: Cyclacel Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05358379
Phase1, Phase2, Recruiting
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
for
EGFRI Induced Acneiform Lesions
Location: Houston TX, Shreveport LA, Tampa FL, Hazard KY,
Sponsor: Lutris Pharma Ltd.
Sex: All
Age: 18+
Code: NCT04759664
Phase2, Recruiting
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
for
Low Risk Myelodysplastic Syndromes
Location: Houston TX, Dallas TX, St Louis MO, Miami FL,
Sponsor: Rigel Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05308264
Phase1, Phase2, Recruiting
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
for
Phase 1, Recurrent Melanoma, Refractory Melanoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06660420
Phase1, Recruiting
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion